Optimization of experimental human leukemia models (review)

Cover Page

Cite item

Full Text

Abstract

Actual problem of assessing immunotherapy prospects including antigenpecific cell therapy using animal models was covered in this review.
Describe the various groups of currently existing animal models and methods of their creating – from different immunodeficient mice to several
variants of tumor cells engraftment in them. The review addresses the possibility of tumor stem cells studying using mouse models for the leukemia treatment with adoptive cell therapy including WT1. Also issues of human leukemia cells migration and proliferation in a mice with
different immunodeficiency degree are discussed. To assess the potential immunotherapy efficacy comparison of immunodeficient mouse model with clinical situation in oncology patients after chemotherapy is proposed.

About the authors

D. D. Pankov

Federal Research Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev, Ministry of Health of Russia

Memorial Sloan-Kettering Cancer Center

Author for correspondence.
Email: pankovd@mskcc.org
Russian Federation

A. G. Rumyantsev

Federal Research Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev, Ministry of Health of Russia

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2012



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-36928 от  21.07.2009.